Dermatophytic Onychomycosis Treatment Market -Industry Analysis and Forecast (2023-2029)


Dermatophytic Onychomycosis Treatment Market was valued at US$ 4.29 Bn in 2022 and is expected to reach US$ 10.34 Bn by 2029 at a CAGR of 13.38%.

Dermatophytic Onychomycosis Treatment Market Dynamics

The Dermatophytic onychomycosis also called as tinea unguium, is a fungal disease of toenails or fingernails that causes ring infection over nails. Trichophyton mentagrophytes and Trichophyton rubrum are mutual strains of fungi responsible for causing dermatophytic onychomycosis.

Major factors influencing the dermatophytic onychomycosis treatment market growth are consistently increasing the prevalence of onychomycosis infections worldwide along with the development of novel medications available commercially for the treatment of onychomycosis infections. Moreover, consistent rise in a geriatric population who are highly susceptible to acquiring the infections along with a rising in treatment rate due to increasing socialization of the individuals are some of the features that would further drive the dermatophytic onychomycosis infections therapeutics market.Dermatophytic Onychomycosis Treatment MarketTo know about the Research Methodology:-Request Free Sample Report

Dermatophytic Onychomycosis Treatment Segment Analysis

The nail paint segment based on production is expected to contribute a larger share to the dermatophytic onychomycosis therapeutics market globally. Nail fungus can be very persistent. Topical treatment with nail polish could take up to one year. Tablets for treating fungal nail infections generally have to be taken for several weeks or months. They are very effective than topical treatments, but they have more side effects.

Drug stores are dominating the global dermatophytic onychomycosis treatment market. The drug stores segment is expected to register the highest CAGR during the forecast period. Independent pharmacies are anticipated to be the second most attractive segment of the global dermatophytic onychomycosis therapeutics market by 2022 end.
New and developing approaches to treat dermatophytic onychomycosis are device-based laser and photodynamic therapy. Many companies have targeted this approach to provide an effective cure for dermatophytic onychomycosis. In 2017, the FDA approved Erchonia’s Lunula laser device, which provides low-level laser therapy to treat nail onychomycosis treatment.

Regional insights

Region-wise, North America is projected to hold a dominant position in the dermatophytic onychomycosis treatment market globally, followed by Europe, due to the high prevalence of dermatophytic onychomycosis and the increasing geriatric population in the U.S. According to the Centre for Disease Control and Prevention in 2022, nail fungus or dermatophytic onychomycosis affects around 26 million people in the U.S. each year.
Global dermatophytic onychomycosis treatment market report includes PESTLE analysis, competitive landscape, and Porter’s five force model. Market attractive analysis wherein all the segments are benchmarked based on the market size, growth rate, and general attractiveness.

Key players are launching innovative products in the dermatophytic onychomycosis treatment market globally, in order to expand their market footprint, addressing the limitations of current therapeutics to give dermatophytic onychomycosis. In 2014, Valeant Pharmaceuticals was granted with Food and Drug Administration (FDA) agreement for its topical product for dermatophytic onychomycosis named Efinaconazole.

Dermatophytic Onychomycosis Treatment Marke, Key Highlights:

Global Dermatophytic Onychomycosis Treatment Marke analysis and forecast, in terms of value.

Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Dermatophytic Onychomycosis Treatment Market

Global Dermatophytic Onychomycosis Treatment Marke segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

The Global Dermatophytic Onychomycosis Treatment Marke strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

Global Dermatophytic Onychomycosis Treatment Marke analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Dermatophytic Onychomycosis Treatment Marke are also profiled.

Dermatophytic Onychomycosis Treatment Market Scope: Inquire before buying






Dermatophytic Onychomycosis Treatment Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 4.29 Bn.




Forecast Period 2023 to 2029 CAGR:
13.38%
Market Size in 2029:
US $ 10.34 Bn.




 Segments Covered:
by Product
Nail Paint
Tablet

Prescription Tablets
Over-the-Counter (OTC) Tablets




by Route of administration
Topical
Oral Therapy




by End-User
Hospitals
Dermatology & Podiatry Clinics
Independent Pharmacies
Mail Order Pharmacies
Drug Stores






by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Dermatophytic Onychomycosis Treatment Market, Key Players

1. Bausch Health Companies
2. Galderma S.A.
3. Celtic Pharma
4. Anacor pharmaceuticals, Inc.
5. Johnson & Johnson
6. Novartis AG
7. Pfizer Inc.
8. GlaxoSmithKline
9. Topica Pharmaceuticals, Inc.
10.Moberg Pharma AB
11.Bayer AG
12.Dr. Reddy’s Laboratories Ltd
13.Allergen, Inc.
14.Cipla Ltd
15.Medimetriks Pharmaceuticals Inc.
16.Sanofi S.A.
17.NovaBiotics Inc.
18.Merz Pharma.

Frequently Asked Questions:

1. Which region has the largest share in Dermatophytic Onychomycosis Treatment Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Dermatophytic Onychomycosis Treatment Market?
Ans: The global market is growing at a CAGR of 13.38% during forecasting period 2023-2029.

3. What is scope of the Global Dermatophytic Onychomycosis Treatment market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Dermatophytic Onychomycosis Treatment market?
Ans: The important key players in the global market are – Bausch Health Companies, Galderma S.A., Celtic Pharma, Anacor pharmaceuticals, Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., GlaxoSmithKline, Topica Pharmaceuticals, Inc., Moberg Pharma AB, Bayer AG, Dr. Reddy’s Laboratories Ltd, Allergen, Inc., Cipla Ltd, Medimetriks Pharmaceuticals Inc., Sanofi S.A., NovaBiotics Inc., and Merz Pharma.

5. What is the study period of this market?
Ans: The Global Dermatophytic Onychomycosis Treatment Market is studied from 2022 to 2029. 





Dermatophytic Onychomycosis Treatment Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Abbreviations

3. Executive Summary
3.1. Global Dermatophytic Onychomycosis Treatment Market Size, by Market Value (US$ Bn)

4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Challenges
4.2.4. Emerging Technology
4.2.5. Opportunities
4.3. Market Analysis
4.3.1. Porter’s Analysis
4.3.2. Value Chain Analysis
4.3.3. Pricing Analysis
4.3.4. Market Risk analysis
4.3.5.Key Trends in Global Dermatophytic Onychomycosis Treatment Market

5. Global Dermatophytic Onychomycosis Treatment Market Analysis and Forecast
5.1. Global Dermatophytic Onychomycosis Treatment Market Analysis and Forecast
5.2. Global Dermatophytic Onychomycosis Treatment Market Size& Y-o-Y Growth Analysis
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Middle East & Africa
5.2.5. South America

6. Global Dermatophytic Onychomycosis Treatment Market Analysis and Forecast, by Product
6.1. Introduction and Definition
6.2. Global Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Product
6.3. Market Size (US$ Bn) Forecast, by Product
6.4. Global Dermatophytic Onychomycosis Treatment Market Analysis, by Product
6.5. Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis, by Product

7. Global Dermatophytic Onychomycosis Treatment Market Analysis and Forecast, by Route of Administration
7.1. Introduction and Definition
7.2. Global Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Route of Administration
7.3. Market Size (US$ Bn) Forecast, by Route of Administration
7.4. Global Dermatophytic Onychomycosis Treatment Market Analysis, by Route of Administration
7.5. Global Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis, by Route of Administration

8. Global Dermatophytic Onychomycosis Treatment Market Analysis and Forecast, by End user
8.1. Introduction and Definition
8.2. Global Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by End user
8.3. Market Size (US$ Bn) Forecast, by End user
8.4. Global Dermatophytic Onychomycosis Treatment Market Analysis, by End user
8.5. Global Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis, by End user

9. Global Dermatophytic Onychomycosis Treatment Market Analysis, by Region
9.1. Global Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Region
9.2. Market Size (US$ Bn) Forecast, by Region
9.3. Global Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis, by Region

10. North America Dermatophytic Onychomycosis Treatment Market Analysis
10.1. North America Dermatophytic Onychomycosis Treatment Market Overview
10.2. North America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Product
10.3. North America Dermatophytic Onychomycosis Treatment Market Forecast, by Product
10.3.1. Nail Paint
10.3.2. Tablet
10.3.2.1. Prescription Tablets
10.3.2.2. Over-the-Counter (OTC) Tablets
10.4. North America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Route of Administration
10.5. North America Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
10.5.1. Topical
10.5.2. Oral Therapy
10.6. North America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by End user
10.7. North America Dermatophytic Onychomycosis Treatment Market Forecast, by End user
10.7.1. Hospitals
10.7.2. Dermatology & Podiatry Clinics
10.7.3. Independent Pharmacies
10.7.4. Mail Order Pharmacies
10.7.5. Drug Stores
10.8. North America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Country
10.9. North America Dermatophytic Onychomycosis Treatment Market Forecast, by Country
10.9.1. U.S
10.9.2. Canada
10.10. North America Dermatophytic Onychomycosis Treatment Market Analysis, by Country
10.11. U.S. Dermatophytic Onychomycosis Treatment Market Forecast, by Product
10.11.1. Nail Paint
10.11.2. Tablet
10.11.2.1. Prescription Tablets
10.11.2.2. Over-the-Counter (OTC) Tablets
10.12. U.S. Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
10.12.1. Topical
10.12.2. Oral Therapy
10.13. U.S. Dermatophytic Onychomycosis Treatment Market Forecast, by End user
10.13.1. Hospitals
10.13.2. Dermatology & Podiatry Clinics
10.13.3. Independent Pharmacies
10.13.4. Mail Order Pharmacies
10.13.5. Drug Stores
10.14. Canada Dermatophytic Onychomycosis Treatment Market Forecast, by Product
10.14.1. Nail Paint
10.14.2. Tablet
10.14.2.1. Prescription Tablets
10.14.2.2. Over-the-Counter (OTC) Tablets
10.15. Canada Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
10.15.1. Topical
10.15.2. Oral Therapy
10.16. Canada Dermatophytic Onychomycosis Treatment Market Forecast, by End user
10.16.1. Hospitals
10.16.2. Dermatology & Podiatry Clinics
10.16.3. Independent Pharmacies
10.16.4. Mail Order Pharmacies
10.16.5. Drug Stores
10.17. North America Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis
10.17.1. by Product
10.17.2. by Route of Administration
10.17.3. by End user
10.18. PEST Analysis
10.19. Key Trends
10.20. Key Developments

11. Europe Dermatophytic Onychomycosis Treatment Market Analysis
11.1. Europe Dermatophytic Onychomycosis Treatment Market Overview
11.2. Europe Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Product
11.3. Europe Dermatophytic Onychomycosis Treatment Market Forecast, by Product
11.3.1. Nail Paint
11.3.2. Tablet
11.3.2.1. Prescription Tablets
11.3.2.2. Over-the-Counter (OTC) Tablets
11.4. Europe Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Route of Administration
11.5. Europe Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
11.5.1. Topical
11.5.2. Oral Therapy
11.6. Europe Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by End user
11.7. Europe Dermatophytic Onychomycosis Treatment Market Forecast, by End user
11.7.1. Hospitals
11.7.2. Dermatology & Podiatry Clinics
11.7.3. Independent Pharmacies
11.7.4. Mail Order Pharmacies
11.7.5. Drug Stores
11.8. Europe Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Country
11.9. Europe Dermatophytic Onychomycosis Treatment Market Forecast, by Country
11.9.1. Germany
11.9.2. U.K.
11.9.3. France
11.9.4. Italy
11.9.5. Spain
11.9.6. Rest of Europe
11.10. Europe Dermatophytic Onychomycosis Treatment Market Analysis, by Country/ Sub-region
11.11. Germany Dermatophytic Onychomycosis Treatment Market Forecast, by Product
11.11.1. Nail Paint
11.11.2. Tablet
11.11.2.1. Prescription Tablets
11.11.2.2. Over-the-Counter (OTC) Tablets
11.12. Germany Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
11.12.1. Topical
11.12.2. Oral Therapy
11.13. Germany Dermatophytic Onychomycosis Treatment Market Forecast, by End user
11.13.1. Hospitals
11.13.2. Dermatology & Podiatry Clinics
11.13.3. Independent Pharmacies
11.13.4. Mail Order Pharmacies
11.13.5. Drug Stores
11.14. U.K. Dermatophytic Onychomycosis Treatment Market Forecast, by Product
11.14.1. Nail Paint
11.14.2. Tablet
11.14.2.1. Prescription Tablets
11.14.2.2. Over-the-Counter (OTC) Tablets
11.15. U.K. Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
11.15.1. Topical
11.15.2. Oral Therapy
11.16. U.K. Dermatophytic Onychomycosis Treatment Market Forecast, by End user
11.16.1. Hospitals
11.16.2. Dermatology & Podiatry Clinics
11.16.3. Independent Pharmacies
11.16.4. Mail Order Pharmacies
11.16.5. Drug Stores
11.17. France Dermatophytic Onychomycosis Treatment Market Forecast, by Product
11.17.1. Nail Paint
11.17.2. Tablet
11.17.2.1. Prescription Tablets
11.17.2.2. Over-the-Counter (OTC) Tablets
11.18. France Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
11.18.1. Topical
11.18.2. Oral Therapy
11.19. France Dermatophytic Onychomycosis Treatment Market Forecast, by End user
11.19.1. Hospitals
11.19.2. Dermatology & Podiatry Clinics
11.19.3. Independent Pharmacies
11.19.4. Mail Order Pharmacies
11.19.5. Drug Stores
11.20. Italy Dermatophytic Onychomycosis Treatment Market Forecast, by Product
11.20.1. Nail Paint
11.20.2. Tablet
11.20.2.1. Prescription Tablets
11.20.2.2. Over-the-Counter (OTC) Tablets
11.21. Italy Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
11.21.1. Topical
11.21.2. Oral Therapy
11.22. Italy Dermatophytic Onychomycosis Treatment Market Forecast, by End user
11.22.1. Hospitals
11.22.2. Dermatology & Podiatry Clinics
11.22.3. Independent Pharmacies
11.22.4. Mail Order Pharmacies
11.22.5. Drug Stores
11.23. Spain Dermatophytic Onychomycosis Treatment Market Forecast, by Product
11.23.1. Nail Paint
11.23.2. Tablet
11.23.2.1. Prescription Tablets
11.23.2.2. Over-the-Counter (OTC) Tablets
11.24. Spain Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
11.24.1. Topical
11.24.2. Oral Therapy
11.25. Spain Dermatophytic Onychomycosis Treatment Market Forecast, by End user
11.25.1. Hospitals
11.25.2. Dermatology & Podiatry Clinics
11.25.3. Independent Pharmacies
11.25.4. Mail Order Pharmacies
11.25.5. Drug Stores
11.26. Rest of Europe Dermatophytic Onychomycosis Treatment Market Forecast, by Product
11.26.1. Nail Paint
11.26.2. Tablet
11.26.2.1. Prescription Tablets
11.26.2.2. Over-the-Counter (OTC) Tablets
11.27. Rest of Europe Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
11.27.1. Topical
11.27.2. Oral Therapy
11.28. Rest of Europe Dermatophytic Onychomycosis Treatment Market Forecast, by End user
11.28.1. Hospitals
11.28.2. Dermatology & Podiatry Clinics
11.28.3. Independent Pharmacies
11.28.4. Mail Order Pharmacies
11.28.5. Drug Stores
11.29. Europe Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis
11.29.1. by Product
11.29.2. by Route of Administration
11.29.3. by End user
11.30. PEST Analysis
11.31. Key Trends
11.32. Key Developments

12. Asia Pacific Dermatophytic Onychomycosis Treatment Market Analysis
12.1. Asia Pacific Dermatophytic Onychomycosis Treatment Market Overview
12.2. Asia Pacific Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Product
12.3. Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by Product
12.3.1. Nail Paint
12.3.2. Tablet
12.3.2.1. Prescription Tablets
12.3.2.2. Over-the-Counter (OTC) Tablets
12.4. Asia Pacific Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Route of Administration
12.5. Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
12.5.1. Topical
12.5.2. Oral Therapy
12.6. Asia Pacific Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by End user
12.7. Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by End user
12.7.1. Hospitals
12.7.2. Dermatology & Podiatry Clinics
12.7.3. Independent Pharmacies
12.7.4. Mail Order Pharmacies
12.7.5. Drug Stores
12.8. Asia Pacific Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Country
12.9. Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by Country
12.9.1. China
12.9.2. India
12.9.3. Japan
12.9.4. ASEAN
12.9.5. Rest of Asia Pacific
12.10. Asia Pacific Dermatophytic Onychomycosis Treatment Market Analysis, by Country/ Sub-region
12.11. China Dermatophytic Onychomycosis Treatment Market Forecast, by Product
12.11.1. Nail Paint
12.11.2. Tablet
12.11.2.1. Prescription Tablets
12.11.2.2. Over-the-Counter (OTC) Tablets
12.12. China Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
12.12.1. Topical
12.12.2. Oral Therapy
12.13. China Dermatophytic Onychomycosis Treatment Market Forecast, by End user
12.13.1. Hospitals
12.13.2. Dermatology & Podiatry Clinics
12.13.3. Independent Pharmacies
12.13.4. Mail Order Pharmacies
12.13.5. Drug Stores
12.14. India Dermatophytic Onychomycosis Treatment Market Forecast, by Product
12.14.1. Nail Paint
12.14.2. Tablet
12.14.2.1. Prescription Tablets
12.14.2.2. Over-the-Counter (OTC) Tablets
12.15. India Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
12.15.1. Topical
12.15.2. Oral Therapy
12.16. India Dermatophytic Onychomycosis Treatment Market Forecast, by End user
12.16.1. Hospitals
12.16.2. Dermatology & Podiatry Clinics
12.16.3. Independent Pharmacies
12.16.4. Mail Order Pharmacies
12.16.5. Drug Stores
12.17. Japan Dermatophytic Onychomycosis Treatment Market Forecast, by Product
12.17.1. Nail Paint
12.17.2. Tablet
12.17.2.1. Prescription Tablets
12.17.2.2. Over-the-Counter (OTC) Tablets
12.18. Japan Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
12.18.1. Topical
12.18.2. Oral Therapy
12.19. Japan Dermatophytic Onychomycosis Treatment Market Forecast, by End user
12.19.1. Hospitals
12.19.2. Dermatology & Podiatry Clinics
12.19.3. Independent Pharmacies
12.19.4. Mail Order Pharmacies
12.19.5. Drug Stores
12.20. ASEAN Dermatophytic Onychomycosis Treatment Market Forecast, by Product
12.20.1. Nail Paint
12.20.2. Tablet
12.20.2.1. Prescription Tablets
12.20.2.2. Over-the-Counter (OTC) Tablets
12.21. ASEAN Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
12.21.1. Topical
12.21.2. Oral Therapy
12.22. ASEAN Dermatophytic Onychomycosis Treatment Market Forecast, by End user
12.22.1. Hospitals
12.22.2. Dermatology & Podiatry Clinics
12.22.3. Independent Pharmacies
12.22.4. Mail Order Pharmacies
12.22.5. Drug Stores
12.23. Rest of Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by Product
12.23.1. Nail Paint
12.23.2. Tablet
12.23.2.1. Prescription Tablets
12.23.2.2. Over-the-Counter (OTC) Tablets
12.24. Rest of Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
12.24.1. Topical
12.24.2. Oral Therapy
12.25. Rest of Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by End user
12.25.1. Hospitals
12.25.2. Dermatology & Podiatry Clinics
12.25.3. Independent Pharmacies
12.25.4. Mail Order Pharmacies
12.25.5. Drug Stores
12.26. Asia Pacific Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis
12.26.1. by Product
12.26.2. by Route of Administration
12.26.3. by End user
12.27. PEST Analysis
12.28. Key Trends
12.29. Key Developments

13. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Analysis
13.1. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Overview
13.2. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Product
13.3. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Product
13.3.1. Nail Paint
13.3.2. Tablet
13.3.2.1. Prescription Tablets
13.3.2.2. Over-the-Counter (OTC) Tablets
13.4. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Route of Administration
13.5. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
13.5.1. Topical
13.5.2. Oral Therapy
13.6. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by End user
13.7. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by End user
13.7.1. Hospitals
13.7.2. Dermatology & Podiatry Clinics
13.7.3. Independent Pharmacies
13.7.4. Mail Order Pharmacies
13.7.5. Drug Stores
13.8. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Country
13.9. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Country
13.9.1. GCC
13.9.2. South Africa
13.9.3. Rest of Middle East & Africa
13.10. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Analysis, by Country/ Sub-region
13.11. GCC Dermatophytic Onychomycosis Treatment Market Forecast, by Product
13.11.1. Nail Paint
13.11.2. Tablet
13.11.2.1. Prescription Tablets
13.11.2.2. Over-the-Counter (OTC) Tablets
13.12. GCC Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
13.12.1. Topical
13.12.2. Oral Therapy
13.13. GCC Dermatophytic Onychomycosis Treatment Market Forecast, by End user
13.13.1. Hospitals
13.13.2. Dermatology & Podiatry Clinics
13.13.3. Independent Pharmacies
13.13.4. Mail Order Pharmacies
13.13.5. Drug Stores
13.14. South Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Product
13.14.1. Nail Paint
13.14.2. Tablet
13.14.2.1. Prescription Tablets
13.14.2.2. Over-the-Counter (OTC) Tablets
13.15. South Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
13.15.1. Topical
13.15.2. Oral Therapy
13.16. South Africa Dermatophytic Onychomycosis Treatment Market Forecast, by End user
13.16.1. Hospitals
13.16.2. Dermatology & Podiatry Clinics
13.16.3. Independent Pharmacies
13.16.4. Mail Order Pharmacies
13.16.5. Drug Stores
13.17. Rest of Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Product
13.17.1. Nail Paint
13.17.2. Tablet
13.17.2.1. Prescription Tablets
13.17.2.2. Over-the-Counter (OTC) Tablets
13.18. Rest of Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
13.18.1. Topical
13.18.2. Oral Therapy
13.19. Rest of Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by End user
13.19.1. Hospitals
13.19.2. Dermatology & Podiatry Clinics
13.19.3. Independent Pharmacies
13.19.4. Mail Order Pharmacies
13.19.5. Drug Stores
13.20. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis
13.20.1. by Product
13.20.2. by Route of Administration
13.20.3. by End user
13.21. PEST Analysis
13.22. Key Trends
13.23. Key Developments

14. South America Dermatophytic Onychomycosis Treatment Market Analysis
14.1. South America Dermatophytic Onychomycosis Treatment Market Overview
14.2. South America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Product
14.3. South America Dermatophytic Onychomycosis Treatment Market Forecast, by Product
14.3.1. Nail Paint
14.3.2. Tablet
14.3.2.1. Prescription Tablets
14.3.2.2. Over-the-Counter (OTC) Tablets
14.4. South America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Route of Administration
14.5. South America Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
14.5.1. Topical
14.5.2. Oral Therapy
14.6. South America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by End user
14.7. South America Dermatophytic Onychomycosis Treatment Market Forecast, by End user
14.7.1. Hospitals
14.7.2. Dermatology & Podiatry Clinics
14.7.3. Independent Pharmacies
14.7.4. Mail Order Pharmacies
14.7.5. Drug Stores
14.8. South America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Country
14.9. South America Dermatophytic Onychomycosis Treatment Market Forecast, by Country
14.9.1. Brazil
14.9.2. Mexico
14.9.3. Rest of South America
14.10. South America Dermatophytic Onychomycosis Treatment Market Analysis, by Country/ Sub-region
14.11. Brazil Dermatophytic Onychomycosis Treatment Market Forecast, by Product
14.11.1. Nail Paint
14.11.2. Tablet
14.11.2.1. Prescription Tablets
14.11.2.2. Over-the-Counter (OTC) Tablets
14.12. Brazil Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
14.12.1. Topical
14.12.2. Oral Therapy
14.13. Brazil Dermatophytic Onychomycosis Treatment Market Forecast, by End user
14.13.1. Hospitals
14.13.2. Dermatology & Podiatry Clinics
14.13.3. Independent Pharmacies
14.13.4. Mail Order Pharmacies
14.13.5. Drug Stores
14.14. Mexico Dermatophytic Onychomycosis Treatment Market Forecast, by Product
14.14.1. Nail Paint
14.14.2. Tablet
14.14.2.1. Prescription Tablets
14.14.2.2. Over-the-Counter (OTC) Tablets
14.15. Mexico Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
14.15.1. Topical
14.15.2. Oral Therapy
14.16. Mexico Dermatophytic Onychomycosis Treatment Market Forecast, by End user
14.16.1. Hospitals
14.16.2. Dermatology & Podiatry Clinics
14.16.3. Independent Pharmacies
14.16.4. Mail Order Pharmacies
14.16.5. Drug Stores
14.17. Research centres Rest of South America Dermatophytic Onychomycosis Treatment Market Forecast, by Product
14.17.1. Nail Paint
14.17.2. Tablet
14.17.2.1. Prescription Tablets
14.17.2.2. Over-the-Counter (OTC) Tablets
14.18. Rest of South America Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration
14.18.1. Topical
14.18.2. Oral Therapy
14.19. Rest of South America Dermatophytic Onychomycosis Treatment Market Forecast, by End user
14.19.1. Hospitals
14.19.2. Dermatology & Podiatry Clinics
14.19.3. Independent Pharmacies
14.19.4. Mail Order Pharmacies
14.19.5. Drug Stores
14.20. South America Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis
14.20.1. by Product
14.20.2. by Route of Administration
14.20.3. by End user
14.21. PEST Analysis
14.22. Key Trends
14.23. Key Developments

15. Competitive Landscape
15.1. Market Share Analysis, by Key Players
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
15.2.2. Market Consolidation
15.2.2.1. M&A by regions, investment, applications
15.2.2.2. M&A Key Players, forward integration, backward integration
15.3. Company Profiles: Key Player
15.3.1. Bausch Health Companies
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Business Strategy
15.3.1.4. Recent Developments
15.3.1.5. Manufacturing Footprint
15.3.2. Galderma S.A.
15.3.3. Celtic Pharma
15.3.4. Anacor pharmaceuticals, Inc.
15.3.5. Johnson & Johnson
15.3.6. Novartis AG
15.3.7. Pfizer Inc.
15.3.8. GlaxoSmithKline
15.3.9. Topica Pharmaceuticals, Inc.
15.3.10. Moberg Pharma AB
15.3.11. Bayer AG
15.3.12. Dr. Reddy’s Laboratories Ltd
15.3.13. Allergen, Inc.
15.3.14. Cipla Ltd
15.3.15. Medimetriks Pharmaceuticals Inc.
15.3.16. Sanofi S.A.
15.3.17. NovaBiotics Inc.
15.3.18. Merz Pharma.

16. Primary Key Insights
  • INQUIRE BEFORE BUYING